An Interview With Geoffrey D. Barnes, MD, MSc

The University of Michigan vascular cardiologist discusses PERT research needs, implementation science in practice, anticoagulation stewardship, and collaborative patient care.

An Interview With Binita Shah, MD, MS, FACC, FSCAI

Dr. Shah discusses the benefit of colchicine in cardiovascular disease, the role of diet after coronary intervention, DEI efforts in interventional cardiology, and more.

An Interview With J. Dawn Abbott, MD, FACC, FSCAI

Dr. Abbott shares her leadership goals and values, insights into the National Cardiovascular Data Registry CathPCI registry, research needs for PCI, and more.

A Personalized Approach to Antiplatelet Therapy

How to use the data to make individual patient decisions.

By Razan Elsayed, MD, and Usman Baber, MD, MS

The ATLANTIS Randomized Trial: Apixaban Versus Standard of Care After TAVI

Insight on the role of oral anticoagulation as default antithrombotic strategy after transcatheter aortic valve implantation.

By Antonio Greco, MD, and Davide Capodanno, MD, PhD

Antithrombotic Therapy After TAVI

Is aspirin enough?

By Antonio Greco, MD, and Davide Capodanno, MD, PhD

Emerging Options for Anticoagulation in LAA Closure

Managing anticoagulation and antiplatelet therapy in patients undergoing percutaneous left atrial appendage closure with the Watchman device.

By Jessica Tilton, PharmD, BCACP; John Shilka, PharmD; Adhir Shroff, MD, MPH; and Vicki Groo, PharmD

Bleeding Avoidance Strategies

Experts offer their experience with acute coronary syndrome protocol and how they approach access sites and handle bleeding events.

With Andrey Espinoza, MD, FACC, FSCAI; Paul A. Gurbel, MD; Sunil V. Rao, MD; and Steven J. Yakubov, MD, FACC, FSCAI

Do the New DAPT Guidelines Result in Any Real Changes in Practice?

With John A. Bittl, MD; Robert Yeh, MD, MSc, MBA; Eric A. Secemsky, MD, MSc; Eric R. Bates, MD; and Issam D. Moussa, MD, FACC, FAHA, FSCAI

Optimal Duration of DAPT

Data and implications of recent trials.

By Sammy Elmariah, MD, MPH, FACC, FAHA

DAPT in STEMI

A panel of experts weighs in on STEMI pharmacology, transmission of prehospital ECGs by emergency medical services, and STEMI best practices for 2016.

With Moderator Andrey Espinoza, MD, FACC, FSCAI; and Panelists Peter B. Berger, MD; Paul A. Gurbel, MD; Charles Pollack, MA, MD, FACEP, FAAEM; and Marc Cohen, MD, FACC

Discharge Management of Patients With Diabetes and ACS

Optimizing long-term outcomes.

By Suzanne V. Arnold, MD, MHA, and Mikhail Kosiborod, MD

Platelet Function Testing for Individualized Care?

An assessment of utility in therapy and future directions.

By David J. Schneider, MD

Sticky Platelets

Using platelet reactivity testing to guide antiplatelet therapy after PCI.

By Tarpan Patel, MD; Adam Bress, PharmD; Sahar Ismail, MD; and Adhir Shroff, MD, MPH

Understanding Medication Adherence

Implications for dual-antiplatelet therapy.

By Marie T. Brown, MD, FACP, and Ted E. Feldman, MD, FESC, FACC, FSCAI

Personalizing Oral Antiplatelet Therapy in PCI

A review of the current agents and choosing the right strategy for your patient.

By Hiren Patel, MD; Adam Bress, PharmD; and Adhir Shroff, MD, MPH

Transitioning to Generic Clopidogrel

As antiplatelet therapy enters a transitional phase to generic clopidogrel, will this change drive more patient-tailored treatment?

By Paul A. Gurbel, MD

DAPT Management for Noncardiac Surgery After PCI

Strategies for treating a challenging patient population.

By Amit B. Sharma, MD; Jason C. Kovacic, MD, PhD; and Annapoorna S. Kini, MD

Optimal Medical Therapy After PCI

Intensive multifactorial intervention to reduce cardiovascular risk.

By Matthew J. Sorrentino, MD, FACC